Lilian Varga Selected Research

Danazol (Azol)

8/2017	[Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].
3/2016	Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.
2/2016	The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
12/2014	Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema.
3/2011	Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?
3/2011	Long-term efficacy of danazol treatment in hereditary angioedema.
4/2010	The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.
5/2008	Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.
4/2005	Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lilian Varga Research Topics

Disease

47	Hereditary Angioedemas 01/2022 - 12/2003
12	Angioedema 01/2022 - 09/2004
5	Edema (Dropsy) 12/2015 - 12/2003
3	Acquired angioedema 01/2021 - 05/2006
3	Neoplasms (Cancer) 03/2011 - 01/2008
3	Atherosclerosis 09/2009 - 04/2005
2	Rare Diseases (Rare Disease) 11/2021 - 01/2011
2	Infections 01/2021 - 09/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013 - 12/2004
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 10/2011
2	Vascular Diseases (Vascular Disease) 09/2009 - 05/2008
2	Ischemic Stroke 09/2009 - 05/2009
1	Erythema 06/2021
1	Hypersensitivity (Allergy) 07/2020
1	Stable Angina 12/2016
1	ST Elevation Myocardial Infarction 12/2016
1	Thromboembolism 03/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Fuchs' Endothelial Dystrophy 04/2014
1	Neuromyelitis Optica (Devic's Disease) 02/2014
1	Pathologic Constriction (Stenosis) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Spontaneous Abortion (Miscarriage) 12/2012
1	Thrombotic Microangiopathies 08/2012
1	Atrophy 03/2011
1	Celiac Disease (Celiac Sprue) 03/2011
1	Anaphylaxis (Anaphylactic Shock) 01/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Pre-Eclampsia (Preeclampsia) 12/2010
1	Pathologic Processes 09/2009
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2009
1	Cerebral Infarction 09/2009
1	Antithrombin III Deficiency 01/2008
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2008
1	Virus Diseases (Viral Diseases) 10/2007

Drug/Important Bio-Agent (IBA)

21	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
9	Danazol (Azol)FDA LinkGeneric 08/2017 - 04/2005
8	AntibodiesIBA 01/2022 - 01/2003
5	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 12/2003
5	BradykininIBA 12/2021 - 10/2015
5	Pharmaceutical PreparationsIBA 07/2020 - 04/2010
5	AutoantibodiesIBA 10/2016 - 02/2007
4	conestat alfaIBA 03/2020 - 11/2008
3	EnzymesIBA 01/2021 - 12/2014
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2008
3	AndrogensIBA 08/2017 - 03/2011
3	Biomarkers (Surrogate Marker)IBA 10/2016 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 03/2011 - 12/2003
2	Factor XII (Hageman Factor)IBA 11/2021 - 10/2016
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2015
2	icatibantIBA 08/2016 - 03/2012
2	Tranexamic Acid (AMCA)FDA Link 03/2016 - 03/2011
2	LectinsIBA 10/2015 - 12/2014
2	Immunoglobulin G (IgG)IBA 01/2012 - 03/2011
2	Immunoglobulin M (IgM)IBA 10/2011 - 01/2011
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2011 - 06/2003
2	C-Reactive ProteinIBA 01/2011 - 06/2003
2	CholesterolIBA 11/2007 - 01/2003
1	Glucosamine (Dona)IBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2021
1	PlasminogenIBA 11/2021
1	Complement C1 (Complement 1)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 06/2021
1	ImmunosorbentsIBA 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 06/2019
1	Atrial Natriuretic Factor (ANF)IBA 04/2016
1	Testosterone (Sustanon)FDA Link 02/2016
1	Arginine Vasopressin (Argipressin)IBA 02/2016
1	Endothelin-1 (Endothelin 1)IBA 02/2016
1	AdrenomedullinIBA 02/2016
1	Thyroid HormonesIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2015
1	Aquaporins (Water Channels)IBA 02/2014
1	Aquaporin 4IBA 02/2014
1	FicolinsIBA 07/2013
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 07/2013
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2012
1	Immunoglobulin E (IgE)IBA 03/2011
1	Protein Glutamine gamma Glutamyltransferase 2IBA 03/2011
1	Glutens (Glutelin)IBA 03/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2011
1	Immunoglobulin A (IgA)IBA 03/2011
1	Starch (Cornstarch)IBA 03/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2011
1	ecallantide FDA Link 01/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2010
1	LDL CholesterolIBA 05/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2008
1	HDL LipoproteinsIBA 05/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2007
1	Histamine Antagonists (Antihistamines)IBA 09/2007
1	Complement C4aIBA 04/2007

Therapy/Procedure

16	Therapeutics 01/2021 - 09/2004
2	Percutaneous Coronary Intervention 12/2016 - 05/2013
2	Aftercare (After-Treatment) 02/2016 - 12/2012
1	Drug Therapy (Chemotherapy) 01/2021
1	Intravenous Infusions 03/2011
1	Gluten-Free Diet 03/2011